The company is projected to achieve 7.2% revenue growth in the upcoming quarter, up from a 5.2% gain in the same period last year, as analysts have largely maintained their estimates over the past month. Keurig Dr Pepper reported $4.31 billion in revenue last quarter, marking a 10.7% year-on-year increase and beating Wall Street’s sales forecasts while narrowly missing analysts’ gross margin estimates. Shares of Keurig Dr Pepper have risen 6.8% over the past month versus a 2.9% average sector gain, and analysts hold an average price target of $34.43, suggesting further upside potential. Keurig Dr Pepper has missed revenue targets multiple times in the last two years, whereas peers Vita Coco delivered flat sales beating forecasts by 6.2% and Philip Morris grew revenue 6.8% in line with consensus.